Mapatumumab is a fully human agonistic monoclonal antibody targeting TRAIL-R1, currently undergoing clinical trials for cancer treatment, including relapsed or refractory non-Hodgkin's lymphoma (NHL). The DrugMonitor™ Anti-Mapatumumab Antibody (VS-1224-YC710) is an anti-drug antibody (ADA) against Mapatumumab. This drug-based antibody is raised in mice immunized with the Mapatumumab. The anti-Mapatumumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Mapatumumab in samples.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Anti-Human TNFRSF10A Recombinant Antibody (Mapatumumab)Recombinant human antibody to Human TNFRSF10A. Mapatumumab (HGS-ETR1) is an experimental human monoclonal antibody for the treatment of cancer.
Afuco™ Anti-TNFRSF10A ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-H48)This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant human antibody to Human TNFRSF10A. It is an experimental human monoclonal antibody for the treatment of cancer.
There are currently no Customer reviews or questions for VS-1224-YC710. Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.